Eyewire News

Retina Community Mourns the Loss of Ramin Tadayoni, MD, PhD

Prof. Ramin Tadayoni, MD, PhD, a giant in the global retina community, has passed away.

Read Story

DigitalOptometrics Surpasses 2 Million Remote Eye Exams

New Ocular Telehealth Program Enables Diabetic Retinopathy Screening

Alivi Health Unveils New Vision Program

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

View All News

Stocks

Sort by:

Change A-Z

AbbVie $168.90 0.60%

Adverum Biotechnologies $11.45 0.97%

Alcon $80.97 0.45%

Aldeyra Therapeutics $3.97 0.89%

Alimera Sciences $3.52 -0.71%

Apellis Pharmaceuticals $48.80 2.43%

Astellas Pharma $9.53 0.32%

Bausch + Lomb $14.98 2.32%

Bausch Health Companies $8.50 0.53%

Bayer $7.36 3.88%

Biogen $193.83 -0.15%

Can-Fite Biopharma $1.98 0.00%

Clearside Biomedical $1.37 -2.84%

Cooper Companies $91.77 1.92%

Eyenovia $0.54 3.97%

EyePoint Pharmaceuticals $17.74 4.63%

Glaukos $100.55 1.62%

Harrow Health $10.57 -0.28%

Hill-Rom $155.96 0.03%

Horizon Therapeutics $116.30 0.00%

InMed Pharmaceuticals $0.28 -0.32%

Iridex Corporation $2.92 1.74%

Johnson & Johnson $149.76 0.43%

Kala Pharmaceuticals $6.33 -3.95%

Kiora Pharmaceuticals $0.49 -1.08%

Lensar $3.26 0.31%

Lineage Cell Therapeutics $1.17 2.19%

MeiraGTx Holdings $5.00 -0.40%

Merck & Company $126.82 -0.09%

National Vision Holdings $18.75 1.68%

NovaBay Pharmaceuticals $0.08 4.14%

Novartis AG Common Stock $97.13 2.11%

Ocugen $1.23 -1.21%

Ocular Therapeutix $5.03 -0.89%

Oculis $11.98 0.25%

Ocuphire Pharma $1.58 4.64%

Omeros Corp. $3.13 1.62%

Osmotica $1.11 -1.77%

Outlook Therapeutics $8.29 2.47%

Palatin Technologies $1.79 4.07%

Regeneron $909.59 1.05%

Regenxbio $15.93 1.85%

Roche $30.91 1.64%

Sight Sciences $5.74 6.89%

STAAR Surgical Company $48.04 3.19%

Takeda Pharmaceutical Company $13.38 0.15%

Tarsus Pharmaceuticals $33.81 4.71%

Viatris $11.32 0.58%

View More Stocks

Cataract

High Astigmatism and Amblyopia

What are the options for improving the vision of this young patient?

Pavel Stodulka, MD, PhD; Brett Mueller, DO, PhD; Stefanie Schmickler, MD; and Abi Tenen, MBBS(Hons), FRANZCO

Cataract and Refractive Surgery Today

.fluid-width-video-wrapper{ margin-bottom: -75px !important; } CASE PRESENTATION A 31-year-old woman presents with a desire for improved vision in her amblyopic left eye. Upon examination, the patient’s corrected distance visual acuity (CDVA) is 0.2 decimal OS with a refraction of +1.75 -5.00 x 10º. Her uncorrected near visual acuity (UNVA) is barely J13 OS and does not improve with her distance refraction. The right eye is slightly amblyopic, and her CDVA is 0.7 OD with a plano refraction. She has worn glasses since childhood when her right eye was patched but does not like them. As a result, the patient currently wears spectacles only for driving. Mild horizontal nystagmus is evident and increases with sideways gaze. Scheimpflug corneal tomography of the left eye finds a central corneal thickness of 526 µm, 4.90 D of regular astigmatism, and an anterior chamber depth of 2.8 mm (Figure 1). The endothelium is healthy, and endothelial cell density measures 2,800 cells/mm2. No signs of dry eye disease and no intraocular pathology are found.

Effective Preoperative Assessment and Management of the Ocular Surface

Tips for optimizing the ocular surface and therefore surgical success.

Priya M. Mathews, MD, MPH

Cataract and Refractive Surgery Today

Beyond DEWS II

An overview of the latest advances in dry eye disease management, treatment innovations, and insights into the condition’s pathophysiology since the landmark TFOS DEWS II report.

Quillan M. Austria, MD, and Christopher E. Starr, MD

Cataract and Refractive Surgery Today

Dry Eye Diagnostics for Beginners

It is possible to start simply and expand offerings later.

Kenneth Beckman, MD, FACS

Cataract and Refractive Surgery Today

The Metaverse in Ophthalmology?

A review of current and upcoming virtual reality simulators for microsurgical training.

Geoffrey Nguyen, MD, and Paul Kang, MD

Cataract and Refractive Surgery Today

IOL Dislocation After Penetrating Keratoplasty

Surgeons discuss how to proceed after dislocation of the IOL–capsular bag complex is observed in a patient’s better-seeing eye.

Audrey R. Talley Rostov, MD; Ashvin Agarwal, MS; Ehud Assia, MD; and Samuel Masket, MD

Cataract and Refractive Surgery Today

04.19.2024

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.12.2024

Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRS

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

Refractive

The Role of Vitamins in Ocular Surface Diseases

Addressing vitamin deficiencies with targeted supplementation can significantly improve outcomes.

Rohit Shetty, MD, PhD, FRCS; Pooja Khamar, MS, FCRS(NN), PhD; and Swaminathan Sethu, bds, msc, PhD

Cataract and Refractive Surgery Today

The transition from a normal physiologic state to a pathologic one in the ocular surface, like other tissues and organs, is influenced by etiologic factors, genetic predisposition, and host response (Figure 1). The extent to which these factors contribute determines whether a patient exhibits a subclinical or clinical phenotype of an ocular surface disorder (Figure 1). Beyond the elimination of etiologic factors, modulating the host response can be advantageous in resolving these conditions due to their critical role in regulating tissue homeostasis.

High Astigmatism and Amblyopia

What are the options for improving the vision of this young patient?

Pavel Stodulka, MD, PhD; Brett Mueller, DO, PhD; Stefanie Schmickler, MD; and Abi Tenen, MBBS(Hons), FRANZCO

Cataract and Refractive Surgery Today

Dry Eye Diagnostics for Beginners

It is possible to start simply and expand offerings later.

Kenneth Beckman, MD, FACS

Cataract and Refractive Surgery Today

50 Years of the ASCRS

Past and present chief medical editors of CRST reflect on the impact ASCRS has had.

Cataract and Refractive Surgery Today

Management of Advanced Glaucoma

Nathan M. Radcliffe, MD; Blake Williamson, MD, MPH; and Gary Wörtz, MD

Eyetube

Foundations: The Journey of Neda Squared in Ophthalmology

Neda Shamie, MD; and Neda Nikpoor, MD

Eyetube

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.11.2024

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgery

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Eyewire News

Stay Updated

Retina

A Reference Guide for OCT Angiography

An illustrative overview of OCTA findings to help you implement this tool in common clinical scenarios.

Ivy Zhu, MD; Nicole L. Decker, BS; and Amani A. Fawzi, MD

Retina Today

AT A GLANCE OCT angiography (OCTA) has several advantages over traditional imaging techniques, including being noninvasive, depth resolved, and rapid. OCTA can distinguish the various vascular networks without obscuration by leakage, making it helpful for characterizing neovascularization and nonperfusion. OCTA is particularly useful in cases of type 1 neovascularization, where sub-retinal pigment epithelium neovascularization can develop without active exudation. En face OCTA and OCT B-scans are complementary and, together, can provide the clinician with a wealth of knowledge. There are several conditions for which OCTA can provide detailed information that would otherwise be time-consuming or impossible to find with traditional techniques. OCT angiography (OCTA) is a noninvasive imaging technique that uses the principles of motion detection to reveal depth-resolved images of the retinal and choroidal vasculature, down to the capillary level.1 OCTA has several advantages over traditional imaging techniques, including being noninvasive (no dye injection), depth resolved, and rapid. A key benefit of OCTA is its ability to distinguish the various vascular networks without obscuration by leakage, making it very helpful for characterizing retinal neovascularization and nonperfusion with precision beyond dye-based angiography. Here, we detail several clinical scenarios in which OCTA can be a useful diagnostic tool and illustrate key imaging features. In general, absence of flow (nonperfusion) is best appreciated with en face images. The presence of abnormal flow is most accurately detected using a combination of en face imaging assisted by the OCT B-scan with flow overlay to pinpoint abnormal flow related to structural pathological changes.

Practice Makes Progress

Marion Munk, MD, and Justis P. Ehlers, MD

Retina Today

Ocular Effects of CAR-T Cell Therapy

Know the risks and potential therapeutic benefits associated with this treatment modality.

Lars H. Andersen, MD; Jaskirat S. Takhar, MD; and Jose J. Echegaray, MD

Retina Today

Determining When to Use Modifiers -58 and -78

Both are used in association with the original surgery, but ultimately serve different purposes.

Joy Woodke, COE, OCS, OCSR

Retina Today

Retina Education on the Atlantic Coast

The 2024 Atlantic Coast Retina Club and Macula Conference packed a punch with cases, lectures, and more.

Jacques Bijon, MD, and Erin Flynn, MD

Retina Today

New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT

Sruthi Arepalli, MD, Vaidehi Dedania, MD, and Rebecca Soares, MD, MPH

Eyetube

04.23.2024

New Ocular Telehealth Program Enables Diabetic Retinopathy Screening

Eyewire News

04.20.2024

Retina Community Mourns the Loss of Ramin Tadayoni, MD, PhD

Eyewire News

04.19.2024

Ocugen Completes Dosing in Phase 1/2 Trial of OCU410 for Geographic Atrophy

Eyewire News

04.18.2024

Ocular Therapeutix Releases Topline Results for Phase 1 Trial of Axpaxli for Diabetic Retinopathy

Eyewire News

Glaucoma

Ethical Global Outreach in Residency Training

Acknowledging how self-interest, altruism, and global health experiences intersect.

Grace Sun, MD, and Alina Husain, BS

Glaucoma Today

During my (G.S.) 10 years of serving as the program director of the ophthalmology residency at Weill Cornell Medicine, I interviewed hundreds of applicants who were interested in global ophthalmology. When asked to describe their interest in global health training, applicants often replied with some variant of the same response: to help those in need and to provide care to underserved populations. When I, in turn, described our international opportunities, I always sensed their surprise, and occasionally their disappointment, at my response: “Your experience may be largely nonsurgical.” In the residency interview setting, I was not able to delve into the complexities surrounding global health experiences. I wanted to share my experience as a Peace Corps volunteer in Nicaragua, where I, too, set out with idealistic (and rather naïve) intentions to “save the world.” I wished I could explain that, although we engage in global health experiences with altruistic intentions, we often stand to gain more from these experiences than do the communities that host us. Given the growing interest in global ophthalmology during residency training,1 it is important to reflect on how best to engage in global health experiences and serve host communities. GLOBAL OPHTHALMOLOGY ROTATIONS In July 2013, the Accreditation Council for Graduate Medical Education began to allow up to 1 month of international rotations to be applied to residency training.2 Since then, a growing number of US ophthalmology residency programs have been adopting global health curricula. At least half of ophthalmology residency programs offer or support resident international experiences,3-5 but the global health curricula offered differs substantially by program. Not all programs have mandatory requirements that residents must meet before practicing abroad, even though many faculty believe additional training outside of the standard ophthalmology curriculum is necessary to practice in an international setting. The lengths of international experiences vary from weeks to months, with the most commonly reported duration being 1 week or less.3 Given residents’ limited preparation for—and the short duration of—global health experiences, it is important to understand the motivations for these experiences from the perspective of residency programs and learners. By offering global health opportunities, US ophthalmology residency programs aim to provide residents with international experiences, deliver humanitarian aid, and engage in medical diplomacy.3,6 Through these rotations, residents gain increased exposure to ophthalmology and other health care systems; broadened clinical, surgical, and research experience; and exposure to other cultures.

Establishing a Glaucoma Practice Fresh Out of Fellowship

Insights and strategies for young ophthalmologists in building a successful, specialized practice.

Emily M. Schehlein, MD

Glaucoma Today

DARC: From Bench to Bedside

Tracing the path of an exploratory retinal biomarker.

Francesca M. Cordeiro, MD, PhD, MRCP, FRCOphth

Glaucoma Today

OMDI as an Alternative to Prostaglandin Analogues in Low or Nonresponders

Joseph F. Panarelli, MD; and Neda Shamie, MD

Eyetube

The Buzz on Eyetube

Glaucoma Today

Genetics: Now or Later?

Why it’s time to know the basics.

Inas F. Aboobakar, MD

Glaucoma Today

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.11.2024

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating Aqueous Outflow Restorative Procedure with OMNI

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Pupil Pod

A case-based podcast hosted by Sila Bal, MD, MPH, featuring all stages of the journey through ophthalmology, from first-year residents to the leading experts.

View Feed

Optometry

Realize the Power of Comanagement

Build community with your local providers to ensure your patients receive the best possible care.

Jeff Banas, OD

Modern Optometry

I am embarrassed to admit it took me a while to truly appreciate the value of social networking, but it is now integral to how I practice optometry. To clarify, when I use the term social networking, I am not referring to social media, although that has its place. Rather, I mean the building of real, lasting relationships based on personal interactions. In the health care industry, networking can come in many forms, from establishing mentors to meeting colleagues and friends across various specialties. Many clinicians focus on what we alone can do for our patients, and we are proud of our abilities to treat and manage various conditions, much to the joy of our patients. However, as the scope of optometric care continues to grow, more of us are becoming more specialized. My practice focuses heavily on refractive surgery, glaucoma, and the anterior segment. We do provide comprehensive eye care, but we refer out for certain conditions. I am knowledgeable about the retina, but I have no problem telling a patient that I would like my retina colleague’s second opinion on what I’m seeing. I view comanagement as an extension of my knowledge base that I use to ensure my patients receive the best care possible.

A Place for House Calls in Optometry

Consider delivering eye care where it’s needed most.

Damaris Raymondi, OD, FAAO

Modern Optometry

Behold, the Power to Reverse Mydriasis Is Here!

The wait is finally over.

Modern Optometry

The Mystery of Cilioretinal Arteries and AMD

Research is beginning to unravel the role these arteries play in the pathogenesis of neovascularization.

Adel Ebraheem, MD, MS, OD

Modern Optometry

Interprofessional Collaboration Pays Off

Working alongside a patient’s primary care physician, the author was able to diagnose Sjögren syndrome and refer her for proper care.

Naureen M. Haroon, OD, MPH, FAAO

Modern Optometry

GA Case Compendium: Multimodal Imaging for Following Geographic Atrophy Over Time

Julie Rodman, OD, MSc, FAAO, FORS

Modern Optometry

04.23.2024

DigitalOptometrics Surpasses 2 Million Remote Eye Exams

Eyewire News

04.10.2024

Orbis Partners and Heidelberg Engineering Partner to Train Eye Care Professionals Around the World

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

04.05.2024

Wearing Glasses Boosts Income by a Third in Low-Income Communities, Finds Landmark New Study

Eyewire News

Business

Want to Achieve Financial Freedom?

Follow these four tips suitable for any optometrist.

Aaron Neufeld, OD

Modern Optometry

As optometrists, we possess a wealth of knowledge on everything eye-related, but how do we become good stewards of the revenue we earn providing exemplary eye care? Truth be told, most optometrists would say they do not have a wealth of investing knowledge. This article aims to change that by sharing four helpful tips that have guided me and many other optometrists in achieving financial freedom. WHAT IS FINANCIAL FREEDOM? Before we get into the tips, let’s agree on what it means to achieve financial freedom. Simply put, it means having enough money and/or assets to live comfortably without needing to work. That is, while your residual income pays the bills, you can focus on what matters most to you, whether that means spending time with family, traveling the world, or continuing to serve your patients in the best manner possible. With disciplined investing practices, financial freedom can come much earlier than your enrollment in Medicare, despite what conventional wisdom might tell you. Consider the following four recommendations and you’ll be on your way. TIP NO.

Tips for Retaining Staff and Keeping Them Happy

A solid team is at the core of any successful practice. Here’s how you can do your part as a leader to ensure employee satisfaction.

Michael J. Cymbor, OD, FAAO; Mila Ioussifova, OD, FAAO, CNS; and Caitlin Morrison, OD, FAAO, FSLS

Modern Optometry

The Good Life

Selina R. McGee, OD, FAAO; Justin Schweitzer, OD, FAAO; and Walter O. Whitley, OD, MBA, FAAO

Modern Optometry

The State of Optometry’s Financial Health

Five takeaways from the largest income survey conducted in optometry.

Aaron Neufeld, OD

Modern Optometry

Determining When to Use Modifiers -58 and -78

Both are used in association with the original surgery, but ultimately serve different purposes.

Joy Woodke, COE, OCS, OCSR

Retina Today

How to Implement the –JZ Modifier

Reporting zero waste when administering therapeutics is going to look a little different this year. Here’s why.

Joy Woodke, COE, OCS, OCSR

Retina Today

04.16.2024

Regeneron Backs $500 Million Venture Capital Fund for Biotechnology Innovation

Eyewire News

04.16.2024

EyeSouth Partners Affiliates With Community Eye Care Specialists in New York

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.12.2024

False Claims Act Complaint Filed Against Regeneron for Fraudulent Drug Pricing Reporting

Eyewire News

Eyewire News

04.20.2024

Retina Community Mourns the Loss of Ramin Tadayoni, MD, PhD

04.23.2024

DigitalOptometrics Surpasses 2 Million Remote Eye Exams

04.23.2024

New Ocular Telehealth Program Enables Diabetic Retinopathy Screening

04.22.2024

Alivi Health Unveils New Vision Program

04.19.2024

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

EyewireTV

04.17.2024

The Latest EyewireTV

Executive Updates

Bausch + Lomb

Alcon

Stocks

Cataract

High Astigmatism and Amblyopia

Effective Preoperative Assessment and Management of the Ocular Surface

Beyond DEWS II

Dry Eye Diagnostics for Beginners

The Metaverse in Ophthalmology?

IOL Dislocation After Penetrating Keratoplasty

04.19.2024

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.12.2024

Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRS

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Refractive

The Role of Vitamins in Ocular Surface Diseases

High Astigmatism and Amblyopia

Dry Eye Diagnostics for Beginners

50 Years of the ASCRS

Management of Advanced Glaucoma

Foundations: The Journey of Neda Squared in Ophthalmology

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.11.2024

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgery

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Stay Updated

Follow Eyewire News

Retina

A Reference Guide for OCT Angiography

Practice Makes Progress

Ocular Effects of CAR-T Cell Therapy

Determining When to Use Modifiers -58 and -78

Retina Education on the Atlantic Coast

New Retina Radio Journal Club with VBS: Comparison of Antiseptics Use for IVT

04.23.2024

New Ocular Telehealth Program Enables Diabetic Retinopathy Screening

04.20.2024

Retina Community Mourns the Loss of Ramin Tadayoni, MD, PhD

04.19.2024

Ocugen Completes Dosing in Phase 1/2 Trial of OCU410 for Geographic Atrophy

04.18.2024

Ocular Therapeutix Releases Topline Results for Phase 1 Trial of Axpaxli for Diabetic Retinopathy

Glaucoma

Ethical Global Outreach in Residency Training

Establishing a Glaucoma Practice Fresh Out of Fellowship

DARC: From Bench to Bedside

OMDI as an Alternative to Prostaglandin Analogues in Low or Nonresponders

The Buzz on Eyetube

Genetics: Now or Later?

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.11.2024

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating Aqueous Outflow Restorative Procedure with OMNI

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug